HERA WU: Open Payments
NPI 1992384234 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 26 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $170 |
| Novartis Pharmaceuticals Corporation | 3 | $167 |
| Galderma Laboratories, L.P. | 1 | $101 |
| GENZYME CORPORATION | 2 | $78 |
| Janssen Biotech, Inc. | 3 | $61 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $53 |
| Amgen Inc. | 2 | $50 |
| UCB, Inc. | 1 | $34 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
Products named: Rhapsido, RINVOQ, NEMLUVIO, DUPIXENT, TREMFYA, SKYRIZI, OTEZLA, ILUMYA.
Industry payments across NC — which companies pay providers there.
